Moscow researchers developed a series of national standards, known as GOST standards, covering the creation, testing, and clinical use of AI technologies.
The decision makes satri-cel the first CAR-T therapy anywhere in the world to receive regulatory approval for a solid tumor indication.
The acquisition ranks among AbbVie’s largest transactions in recent years and reflects the company’s strategy to expand its next-generation immunology medicines as competition intensifies across the sector.
Mumbai-based Innovcare Lifesciences operates across the Indian market and focuses on marketing, distributing, and selling pharmaceutical products, nutraceuticals, and cosmeceuticals.
Under the agreement, Biogen will integrate RayThera’s portfolio of anti-inflammatory and immune-modulating candidates into its broader research and development engine.
Researchers will assess the drug’s efficacy and safety in patients with acute coronary syndrome (ACS), recent myocardial infarction, ischemic stroke, and peripheral arterial disease.
The Respiratory Summit 2026, held in London, brought together representatives from the asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and chronic rhinosinusitis communities for the first time under a shared prevention agenda.
The Commission argued that without the divestitures, the merged company could gain the ability to exert unilateral control over pricing in these markets.
This broader licence gives AviadoBio the flexibility to explore new development pathways and external collaborations while continuing to advance its central nervous system pipeline.
Novo Nordisk invested 3.5 billion Czech koruna (US$168 million) in modernisation works following its US$200 million acquisition of the facility.